Includes correspondence between Renwick and Dr David E Anderson concerning a linkage study into nevoid basal cell carcinoma syndrome, Renwick's comments on Dr Andersons paper titled Linkage analysis of the nevoid basal cell carcinoma syndrome, and related pedigree charts.
NV, Nevoid basal cell carcinoma
- Reference
- GB 248 UGC 155/3/3/68
- Dates of Creation
- 20 Apr 1967-22 Mar 1968
- Physical Description
- 1 article (24 pages), 37 loose pages
Scope and Content
Access Information
RESTRICTED ACCESS.
Please contact the duty archivist to apply for permission to view this material.
AA, Congenital analgesiaUGC 155/3/3/1
AD, Adynamia episodicaUGC 155/3/3/3
AF, Abnormal fibrinogenUGC 155/3/3/5
AH, AchondroplasiaUGC 155/3/3/6
AO family pedigreeUGC 155/3/3/8
AT2, Friedreich's AtaxiaUGC 155/3/3/10
BM, Bloom's SyndromeUGC 155/3/3/13
BP, Bishop pedigree correspondenceUGC 155/3/3/14
CK, Polycystic kidneysUGC 155/3/3/18
CO, Co a antigenUGC 155/3/3/20
CP, CamptodactylyUGC 155/3/3/21
CardiomyopathyUGC 155/3/3/23
DH, Dermatitis herpetiformisUGC 155/3/3/27
DW, DwarfismUGC 155/3/3/30
EA, Epithelioma adenoidesUGC 155/3/3/31
EC, EctrodactylyUGC 155/3/3/33
EN, En a antigenUGC 155/3/3/35
GA, GalactosaemiaUGC 155/3/3/37
GB, Jobbins antigenUGC 155/3/3/38
GE, Ge antigenUGC 155/3/3/39
GI, Giant WBCUGC 155/3/3/40
GL, Renal glycosuriaUGC 155/3/3/41
GO, Gonzalez antigenUGC 155/3/3/42
HE, Haemolytic anaemiaUGC 155/3/3/45
HM, Holt-OramUGC 155/3/3/46
HU, Hunter antigenUGC 155/3/3/47
H22, unidentified diseaseUGC 155/3/3/48
H33, unidentified diseaseUGC 155/3/3/49
II, unidentified diseaseUGC 155/3/3/51
INH, unidentified diseaseUGC 155/3/3/52
KA, Kartagener's SyndromeUGC 155/3/3/53
KN, KoilonychiaUGC 155/3/3/54
LE, Ectopia lentisUGC 155/3/3/56
LI, Lipoma draft pedigree chartUGC 155/3/3/57
LS, Laustia pedigreesUGC 155/3/3/58
MA, Marfan's SyndromeUGC 155/3/3/59
MI, Milroy's DiseaseUGC 155/3/3/61
MT, Mt a antigenUGC 155/3/3/62
Papers on acoustic neuromaniaUGC 155/3/3/66
NV, Nevoid basal cell carcinomaUGC 155/3/3/68
NY, NystagmusUGC 155/3/3/69
OA, Optic atrophyUGC 155/3/3/70
OI, Osteogenesis imperfectaUGC 155/3/3/71
OP, Oculo-pharyngeal myopathyUGC 155/3/3/72
OT, OtosclerosisUGC 155/3/3/73
PD, PolydactylyUGC 155/3/3/75
PO1, Familial polyposis coliUGC 155/3/3/78
PO2, Gardner's SyndromeUGC 155/3/3/79
PR, Pre-auricular sinusUGC 155/3/3/80
PV, Acro-Pectoro-Vertebral DysplasiaUGC 155/3/3/81
PX, Xeroderma pigmentosumUGC 155/3/3/82
RA, Red cell antigenUGC 155/3/3/84
RDM, Pseudo-inflammatory macular dystrophyUGC 155/3/3/86
RN, Radicular neuropathyUGC 155/3/3/87
RP, retinitus pigmentosaUGC 155/3/3/88
SH, Short palateUGC 155/3/3/91
SW, Swann antigenUGC 155/3/3/93
SZ, unidentified diseaseUGC 155/3/3/95
TB, Thyroxine bindingUGC 155/3/3/97
TE, TelangiectasiaUGC 155/3/3/98
TF, Transferrin locusUGC 155/3/3/99
Torkildsen antigenUGC 155/3/3/100
TP, Triosephosphate isomerase deficiencyUGC 155/3/3/101
TS, Tuberous sclerosisUGC 155/3/3/102
WA, Waardenburg's SyndromeUGC 155/3/3/104
WE, antigen VelUGC 155/3/3/105
Y pedigree chartsUGC 155/3/3/108
Z pedigree chartsUGC 155/3/3/109